These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22513979)

  • 1. Coordinated expression of galectin-3 and caveolin-1 in thyroid cancer.
    Shankar J; Wiseman SM; Meng F; Kasaian K; Strugnell S; Mofid A; Gown A; Jones SJ; Nabi IR
    J Pathol; 2012 Sep; 228(1):56-66. PubMed ID: 22513979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galectin-3 Overrides PTRF/Cavin-1 Reduction of PC3 Prostate Cancer Cell Migration.
    Meng F; Joshi B; Nabi IR
    PLoS One; 2015; 10(5):e0126056. PubMed ID: 25942420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The investigation of galectin-3 in diseases of the thyroid gland.
    Kovács RB; Földes J; Winkler G; Bodó M; Sápi Z
    Eur J Endocrinol; 2003 Nov; 149(5):449-53. PubMed ID: 14585093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression and clinical significance of galectin-3 in well-differentiated thyroid carcinoma].
    Ouyang D; Chen FJ; Wei MW; Yang AK; Chen ZQ; Li QL; Chen YF
    Ai Zheng; 2005 Nov; 24(11):1367-71. PubMed ID: 16552965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions.
    Herrmann ME; LiVolsi VA; Pasha TL; Roberts SA; Wojcik EM; Baloch ZW
    Arch Pathol Lab Med; 2002 Jun; 126(6):710-3. PubMed ID: 12033961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms.
    Aron M; Kapila K; Verma K
    Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors.
    Prasad ML; Pellegata NS; Huang Y; Nagaraja HN; de la Chapelle A; Kloos RT
    Mod Pathol; 2005 Jan; 18(1):48-57. PubMed ID: 15272279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of focal adhesion kinase in thyroid cancer: immunohistochemical study.
    Kim SJ; Park JW; Yoon JS; Mok JO; Kim YJ; Park HK; Kim CH; Byun DW; Lee YJ; Jin SY; Suh KI; Yoo MH
    J Korean Med Sci; 2004 Oct; 19(5):710-5. PubMed ID: 15483349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules.
    Abd-El Raouf SM; Ibrahim TR
    Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galectin-3 cytotest in thyroid follicular neoplasia: a prospective, monoinstitutional study.
    Pennelli G; Mian C; Pelizzo MR; Naccamulli D; Piotto A; Girelli ME; Mescoli C; Rugge M
    Acta Cytol; 2009; 53(5):533-9. PubMed ID: 19798881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia.
    Coli A; Bigotti G; Zucchetti F; Negro F; Massi G
    Histopathology; 2002 Jan; 40(1):80-7. PubMed ID: 11903601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-3 and CD44v6 positivity by RT-PCR method in fine needle aspirates of benign thyroid lesions.
    Matesa N; Samija I; Kusić Z
    Cytopathology; 2007 Apr; 18(2):112-6. PubMed ID: 17397496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma.
    Jakubiak-Wielganowicz M; Kubiak R; Sygut J; Pomorski L; Kordek R
    Pol J Pathol; 2003; 54(2):111-5. PubMed ID: 14575419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic role of HBME-1, galectin-3, and β-catenin in poorly differentiated and anaplastic thyroid carcinomas.
    Rossi ED; Straccia P; Palumbo M; Stigliano E; Revelli L; Lombardi CP; Santeusanio G; Pontecorvi A; Fadda G
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):237-41. PubMed ID: 23235344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of papillary thyroid carcinoma-associated molecular markers and their significance in follicular epithelial dysplasia with papillary thyroid carcinoma-like nuclear alterations in Hashimoto's thyroiditis.
    Ma H; Yan J; Zhang C; Qin S; Qin L; Liu L; Wang X; Li N
    Int J Clin Exp Pathol; 2014; 7(11):7999-8007. PubMed ID: 25550843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expressions of RASSF1A, Galectin-3 and TPO mRNA in papillary thyroid carcinoma and their clinical significance].
    Xu MR; Chen Y; Zhou SR; Chi MM; Chen SL; Liu LY
    Zhonghua Zhong Liu Za Zhi; 2009 May; 31(5):356-60. PubMed ID: 19799084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer.
    Sunaga N; Miyajima K; Suzuki M; Sato M; White MA; Ramirez RD; Shay JW; Gazdar AF; Minna JD
    Cancer Res; 2004 Jun; 64(12):4277-85. PubMed ID: 15205342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant l1 cell adhesion molecule affects tumor behavior and chemosensitivity in anaplastic thyroid carcinoma.
    Kim KS; Min JK; Liang ZL; Lee K; Lee JU; Bae KH; Lee MH; Lee SE; Ryu MJ; Kim SJ; Kim YK; Choi MJ; Jo YS; Kim JM; Shong M
    Clin Cancer Res; 2012 Jun; 18(11):3071-8. PubMed ID: 22472175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC.
    Prasad ML; Huang Y; Pellegata NS; de la Chapelle A; Kloos RT
    Histopathology; 2004 Jul; 45(1):39-46. PubMed ID: 15228442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular classification of thyroid nodules by cytology.
    Pagedar NA; Chen DH; Wasman JK; Savvides P; Schluchter MD; Wilhelm SM; Lavertu P
    Laryngoscope; 2008 Apr; 118(4):692-6. PubMed ID: 18094649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.